Print

IDEA EV06

A phase I double blind placebo-controlled clinical trial to evaluate the safety and immunogenicity of the combination of DNA-HIV-PT123 and AIDSVAX ? B/E in HIV-1-uninfected adult participants with or without underlying Schistosoma mansoni (S. mansoni) infection

Trial Details:

I Completed
EuroVacc Foundation; IAVI
DNA-HIV-PT123,AIDSVAX B/E DNA: clade C ZM96 Gag and gp140, CN54 Pol-Nef. Protein: clade B (MN) HIVgp120 glycoprotein clade E (A244) HIV gp120 glycoprotein
DNA-HIV-PT123 DNA
AIDSVAX B/E Protein
Uganda 72
NCT02376582
https://www.clinicaltrials.gov/ct2/show/NCT02376582?term=hiv+and+vaccine&lup_s=02%2F22%2F2015&lup_d=14&show_rss=Y&sel_rss=mod14